Home » Blog
Actos Linked to Bladder Cancer
Date: October 21, 2011 Author: Tony Edwards Category: Consumer Alerts
Recent research conducted by the U.S. Food and Drug Administration shows that there is a strong link between prolonged Actos-use and bladder cancer. Pioglitazone, the active ingredient in Actos, is an oral medication prescribed to patients with Type 2 diabetes. The FDA
